Long term outcomes following hospital admission for sepsis using relative survival analysis: A prospective cohort study of 1,092 patients with 5 year follow up

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Davis, Joshua S ^a,b   He, Vincent ^a   Anstey, Nicholas M ^a,b   Condon, John R ^a  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INDIGENOUS AUSTRALIAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEX DIFFERENCE; SURVIVAL; COMORBIDITY; HOSPITALIZATION; INTENSIVE CARE UNIT; MIDDLE AGED;

ADULT; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; SEPSIS; SURVIVAL ANALYSIS;

EID: 84915778551     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112224     Document Type: Article

References (39)

1. Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, et al. (2003) Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 168: 77-84.
2. Angus DC, Pereira CA, Silva E (2006) Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets 6: 207-212.
3. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554.
4. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699-709.
5. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, et al. (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. Jama 273: 934-941.
6. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, et al. (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247-2256.
7. Vincent JL (2004) Endpoints in sepsis trials: more than just 28-day mortality? Crit Care Med 32: S209-213.
8. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, et al. (2010) Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med 38: 1276-1283.
9. Storgaard M, Hallas J, Gahrn-Hansen B, Pedersen SS, Pedersen C, et al. (2013) Short- and long-term mortality in patients with community-acquired severe sepsis and septic shock. Scand J Infect Dis.
10. Lemay AC, Anzueto A, Restrepo MI, Mortensen EM (2013) Predictors of Long-term Mortality After Severe Sepsis in the Elderly. Am J Med Sci.
11. Dick A, Liu H, Zwanziger J, Perencevich E, Furuya EY, et al. (2012) Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia. BMC Health Serv Res 12: 432.
12. Karlsson S, Ruokonen E, Varpula T, Ala-Kokko TI, Pettila V (2009) Long-term outcome and quality-adjusted life years after severe sepsis. Crit Care Med 37: 1268-1274.
13. Quartin AA, Schein RM, Kett DH, Peduzzi PN (1997) Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 277: 1058-1063.
14. Peake SL, Bailey M, Bellomo R, Cameron PA, Cross A, et al. (2009) Australasian resuscitation of sepsis evaluation (ARISE): A multi-centre, prospective, inception cohort study. Resuscitation 80: 811-818.
15. Esteban A, Frutos-Vivar F, Ferguson ND, Penuelas O, Lorente JA, et al. (2007) Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med 35: 1284-1289.
16. Ollendorf DA, Fendrick AM, Massey K, Williams GR, Oster G (2002) Is sepsis accurately coded on hospital bills? Value Health 5: 79-81.
17. Dent OF, Chapuis PH, Renwick AA, Bokey EL (2009) The importance of tumor stage and relative survival analysis for the association between sex and survival after resection of colorectal cancer. Ann Surg 249: 402-408.
18. Scoll BJ, Wong YN, Egleston BL, Kunkle DA, Saad IR, et al. (2009) Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. J Urol 181: 506-511.
19. Eerola H, Vahteristo P, Sarantaus L, Kyyronen P, Pyrhonen S, et al. (2001) Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int J Cancer 93: 368-372.
20. Ghelani D, Moran JL, Sloggett A, Leeson RJ, Peake SL (2009) Long-term survival of intensive care and hospital patient cohorts compared with the general Australian population: a relative survival approach. J Eval Clin Pract 15: 425-435.
21. Davis JS, Cheng AC, McMillan M, Humphrey AB, Stephens DP, et al. (2011) Sepsis in the tropical Top End of Australia's Northern Territory: disease burden and impact on Indigenous Australians. Med J Aust 194: 519-524.
22. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655.
23. Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47: 1245-1251.
24. Dickman PW, Sloggett A, Hills M, Hakulinen T (2004) Regression models for relative survival. Statistics in medicine 23: 51-64.
25. Lambert PC, Royston P (2009) Further development of flexible parametric models for survival analysis. Stata Journal 9: 265.
26. Dickman PW, Coviello E, Hills M (2009) Estimating and modelling relative survival. The Stata Journal.
27. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, et al. (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167: 1655-1663.
28. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, et al. (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306: 2594-2605.
29. Leentjens J, Kox M, van der Hoeven JG, Netea MG, Pickkers P (2013) Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change? Am J Respir Crit Care Med 187: 1287-1293.
30. Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101: 3765-3777.
31. Hack CE, Zeerleder S (2001) The endothelium in sepsis: source of and a target for inflammation. Crit Care Med 29: S21-27.
32. Hollenberg SM, Cunnion RE (1994) Endothelial and vascular smooth muscle function in sepsis. J Crit Care 9: 262-280.
33. Baker CH (1994) Vascular endothelium in sepsis and endotoxemia. J Fla Med Assoc 81: 119-122.
34. Davis JS, Yeo TW, Piera KA, Woodberry T, Celermajer DS, et al. (2010) Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Crit Care 14: R89.
35. Davis JS, Yeo TW, Thomas JH, McMillan M, Darcy CJ, et al. (2009) Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care 13: R155.
36. Feigin VL, Anderson CS, Mhurchu CN (2002) Systemic inflammation, endothelial dysfunction, dietary fatty acids and micronutrients as risk factors for stroke: a selective review. Cerebrovasc Dis 13: 219-224.
37. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, et al. (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106: 653-658.
38. Davis JS, Darcy CJ, Yeo TW, Jones C, McNeil YR, et al. (2011) Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PLoS One 6: e17260.
39. Rubulotta F, Marshall JC, Ramsay G, Nelson D, Levy M, et al. (2009) Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis. Crit Care Med 37: 1329-1335.